The Effect of Medical Cooperation in the CKD Patients: 10-Year Multicenter Cohort Study
Authors:
- Yasuhiro OnishiYOYasuhiro Onishi
- Haruhito A. UchidaHaruhito A. Uchida
- Yohei MaeshimaYMYohei Maeshima
- Yuka OkuyamaYOYuka Okuyama
- Nozomu OtakaNONozomu Otaka
- Haruyo UjikeHUHaruyo Ujike
- Keiko TanakaKTKeiko Tanaka
- Hidemi TakeuchiHTHidemi Takeuchi
- Kenji TsujiKenji Tsuji
- Masashi KitagawaMKMasashi Kitagawa
- Katsuyuki TanabeKTKatsuyuki Tanabe
- Hiroshi MorinagaHMHiroshi Morinaga
Open Access
- 26 March 2023
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 13 (4) , 582
Abstract
Introduction: While chronic kidney disease (CKD) is one of the most important contributors to mortality from non-communicable diseases, the number of nephrologists is limited worldwide. Medical cooperation is a system of cooperation between primary care physicians and nephrological institutions, consisting of nephrologists and multidisciplinary care teams. Although it has been reported that multidisciplinary care teams contribute to the prevention of worsening renal functions and cardiovascular events, there are few studies on the effect of a medical cooperation system. Methods: We aimed to evaluate the effect of medical cooperation on all-cause mortality and renal prognosis in patients with CKD. One hundred and sixty-eight patients who visited the one hundred and sixty-three clinics and seven general hospitals of Okayama city were recruited between December 2009 and September 2016, and one hundred twenty-three patients were classified into a medical cooperation group. The outcome was defined as the incidence of all-cause mortality, or renal composite outcome (end-stage renal disease or 50% eGFR decline). We evaluated the effects on renal composite outcome and pre-ESRD mortality while incorporating the competing risk for the alternate outcome into a Fine–Gray subdistribution hazard model. Results: The medical cooperation group had more patients with glomerulonephritis (35.0% vs. 2.2%) and less nephrosclerosis (35.0% vs. 64.5%) than the primary care group. Throughout the follow-up period of 5.59 ± 2.78 years, 23 participants (13.7%) died, 41 participants (24.4%) reached 50% decline in eGFR, and 37 participants (22.0%) developed end-stage renal disease (ESRD). All-cause mortality was significantly reduced by medical cooperation (sHR 0.297, 95% CI 0.105–0.835, p = 0.021). However, there was a significant association between medical cooperation and CKD progression (sHR 3.069, 95% CI 1.225–7.687, p = 0.017). Conclusion: We evaluated mortality and ESRD using a CKD cohort with a long-term observation period and concluded that medical cooperation might be expected to influence the quality of medical care in the patients with CKD.Keywords
This publication has 41 references indexed in Scilit:
- Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice GuidelineAnnals of Internal Medicine, 2013
- The contribution of chronic kidney disease to the global burden of major noncommunicable diseasesKidney International, 2011
- A Nurse-coordinated Model of Care versus Usual Care for Stage 3/4 Chronic Kidney Disease in the CommunityClinical Journal of the American Society of Nephrology, 2011
- Multidisciplinary Team Care May Slow the Rate of Decline in Renal FunctionClinical Journal of the American Society of Nephrology, 2011
- Revised Equations for Estimated GFR From Serum Creatinine in JapanAmerican Journal of Kidney Diseases, 2009
- High phosphate content beverages in dialysis patients: Relevance for hyperphosphatemia and cardiovascular riskNutrition, Metabolism and Cardiovascular Diseases, 2008
- Effect of a Multifactorial Intervention on Mortality in Type 2 DiabetesNew England Journal of Medicine, 2008
- Association between Multidisciplinary Care and Survival for Elderly Patients with Chronic Kidney DiseaseJournal of the American Society of Nephrology, 2007
- The need for early nephrology referralKidney International, 2005
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999